Johnson & Johnson

$230.47
USD
Last updated on --.
24h volume4.30M
24h highest234.43 USD
24h lowest229.22 USD
24h Price movement-1.65%

JNJ recent prices

24 Hours
-1.65%-$3.860
30 days
+2.28%+$5.138
60 days
-2.54%-$6.100
90 days
-5.34%-$13.00

Key data

Previous close234.34 USD
Market cap552.02B USD
Volume4.30M
P/E ratio26.240000
Dividend yield (TTM)0.02%
Dividend amount1.3400 USD
Next ex-dividend dateMay 26, 2026
Next payment dateJun 9, 2026
EPS diluted (TTM)8.7400 USD
Net income (FY)21.04B USD
Revenue (FY)96.36B USD
Last report dateApr 22, 2026

About Johnson & Johnson

PHARMACEUTICAL PREPARATIONS
HeadquartersNEW BRUNSWICK
Employees (FY)140.80K
Revenue per employee (FY)684.39K USD
Net income per employee (FY)149.43K USD
Listed onNew York Stock Exchange
Official website

JNJ conversion tables

JNJJNJ
USDUSD
0.5 JNJ115.23 USD
1 JNJ230.47 USD
5 JNJ1,152.39 USD
10 JNJ2,304.78 USD
USDUSD
JNJJNJ
0.5 USD0.0021694 JNJ
1 USD0.0043388 JNJ
5 USD0.021694 JNJ
10 USD0.043388 JNJ

FAQ

JNJ is trading at $230.47, -1.65% over the last 24 hours. Track live moves on the price chart at the top of this page.
The JNJ stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. JNJ is currently trading at $230.47, -1.65% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on JNJ price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. JNJ's P/E ratio is currently 26.240000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from JNJ; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against JNJ's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Johnson & Johnson's market cap is currently 552.02B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume4.30M
24h highest234.43 USD
24h lowest229.22 USD
24h Price movement-1.65%
JNJJNJ
USDUSD
Start trade with JNJ Perpetual